Adderall one of many drugs, medical supplies at risk
Resilinc
NOVEMBER 22, 2022
In October, the FDA announced a shortage of ADHD drug Adderall, with leading manufacturer Teva Pharmaceuticals forecasting that its generic brands would be in short supply until March 2023. Pharma consulting and research firm Advisory Group reported Nov. As covered in Resilinc’s April blog , U.S.
Let's personalize your content